IFG Advisory LLC Cuts Stake in iShares Biotechnology ETF $IBB

IFG Advisory LLC decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 27.5% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,985 shares of the financial services provider’s stock after selling 1,130 shares during the period. IFG Advisory LLC’s holdings in iShares Biotechnology ETF were worth $378,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Arkadios Wealth Advisors raised its holdings in iShares Biotechnology ETF by 13.6% during the 2nd quarter. Arkadios Wealth Advisors now owns 6,917 shares of the financial services provider’s stock valued at $875,000 after buying an additional 828 shares during the last quarter. World Investment Advisors raised its holdings in iShares Biotechnology ETF by 10.4% in the 2nd quarter. World Investment Advisors now owns 7,684 shares of the financial services provider’s stock worth $972,000 after purchasing an additional 721 shares in the last quarter. Quaker Wealth Management LLC raised its holdings in iShares Biotechnology ETF by 200.0% in the 2nd quarter. Quaker Wealth Management LLC now owns 969 shares of the financial services provider’s stock worth $123,000 after purchasing an additional 1,938 shares in the last quarter. Ashton Thomas Private Wealth LLC raised its holdings in iShares Biotechnology ETF by 769.9% in the 2nd quarter. Ashton Thomas Private Wealth LLC now owns 63,691 shares of the financial services provider’s stock worth $8,058,000 after purchasing an additional 56,369 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in iShares Biotechnology ETF by 5.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 56,079 shares of the financial services provider’s stock worth $7,095,000 after purchasing an additional 3,051 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $157.46 on Tuesday. The firm has a fifty day simple moving average of $147.19 and a two-hundred day simple moving average of $134.68. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $159.79.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.